News
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...
Novo Nordisk A/S (NYSE:NVO) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company discontinued ...
Novo Nordisk is expanding access to its drug Wegovy through a new partnership with WeightWatchers, days after cutting ties with telehealth firm Hims & Hers. Starting July 1, WeightWatchers will ...
Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 10 Stocks Delivering Eye-Popping Gains. Hims & Hers rebounded by 11.76 ...
A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...
The talk show host - who once topped the scales at 237lbs in 1992 - finally reached her 160lb goal weight in 2023 after ...
19h
Us Weekly on MSNJenny Mollen Reflects on Microdosing GLP1 and How it Landed Her in the ERJenny Mollen opened up about how microdosing GLP1 medication ended up sending her to the emergency room. "I just posted a follow-up to my piece about Tirzepatide and microdosing," Mollen, 46, said in ...
Meta Platforms, Inc. (NASDAQ:META) is one of the 13 Best Long Term Growth Stocks to Invest in Right Now. On June 24, DBS analyst Sachin Mittal maintained a Buy rating on Meta Platforms, Inc.
The Mounjaro weight-loss jab is now available from GPs the NHS, but only for a limited group of patients with a BMI over 35 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results